Willebrand factor in hemostasis in the in vitro bleeding time

Area of Science:

• Biomedical Science
• Hematology
• Vascular Biology

Background:

• Hemostasis is a complex process crucial for preventing blood loss.
• Von Willebrand factor (vWF) is a key protein involved in platelet adhesion and aggregation.
• Deficiencies in vWF lead to bleeding disorders like von Willebrand disease.

Purpose of the Study:

• To investigate the role of plasmatic Willebrand factor in in vitro hemostasis.
• To determine the necessity of vWF for platelet plug formation in a simulated wound model.

Main Methods:

• An in vitro system using heparinized porcine blood and plasma flowing through a 5-mm skin incision was established.
• Exuded blood volume was measured, and incision sites were examined microscopically.
• Immunofluorescence was used to detect Willebrand factor in platelet plugs.

Main Results:

• Normal blood formed a platelet plug, stopping blood flow, which stained positive for Willebrand factor.
• Blood from von Willebrand pigs showed continuous flow without platelet plug formation.
• Addition of normal plasma or purified Willebrand factor corrected the hemostasis defect in von Willebrand blood.
• Immunological inhibition of Willebrand factor in normal blood delayed hemostasis.

Conclusions:

• Plasmatic Willebrand factor plays an essential role in in vitro hemostasis.
• vWF is critical for the formation of platelet plugs, thereby enabling effective clot formation.
• This study underscores the significance of vWF in the primary hemostatic response.